ArticleNano letters2025
Ag Nanocrystals Intercalated Muscovite Mesocrystal for Large-Scale 3D SERS.
Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmonic nanocrystals represent one of the most fascinating emerging research fields and hold great promise for a wide range of new applications, including surface-enhanced Raman spectroscopy (SERS) and plasmon-related devices. Here, we present a mesocrystal consisting of 3D Ag nanocrystals (NCs) with the same orientation intercalated in a 2D muscovite crystal via a two-step hydrothermal process for a novel SERS platform. The fabricated Ag NCs/mica mesocrystal possesses high crystallinity, uniform size, and extensive distribution to benefit the SERS-active plasmon area and strong plasmon resonance in the visible spectral range. Furthermore, the SERS application potential was demonstrated through Raman spectra of crystal violet and rhodamine 6G molecules on a Ag NCs/mica mesocrystal with detection limits as low as 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.